"Comparing Methotrexate Usage Techniques to Prevent Proliferative Vitreoretinopaty After Retinal Detachment Vitrectomy"
NCT06289205
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Proliferative Vitreoretinopathy
Interventions
DRUG:
Methotrexate
Sponsor
University of Health Sciences Lahore